Primary |
Epilepsy |
36.2% |
Convulsion |
22.6% |
Partial Seizures |
18.3% |
Product Used For Unknown Indication |
14.5% |
Post-traumatic Epilepsy |
2.3% |
Partial Seizures With Secondary Generalisation |
1.7% |
Lennox-gastaut Syndrome |
1.4% |
Back Pain |
0.6% |
Migraine |
0.6% |
Arrhythmia |
0.3% |
Complex Partial Seizures |
0.3% |
Depression |
0.3% |
Seizure Cluster |
0.3% |
Seizures |
0.3% |
Temporal Lobe Epilepsy |
0.3% |
|
Urinary Retention |
34.4% |
Convulsion |
11.9% |
Chromaturia |
6.6% |
Epilepsy |
6.6% |
Skin Discolouration |
3.3% |
Somnolence |
3.3% |
Urinary Hesitation |
3.3% |
Aggression |
2.6% |
Diarrhoea |
2.6% |
Fatigue |
2.6% |
Psychotic Disorder |
2.6% |
Rash |
2.6% |
Sudden Unexplained Death In Epilepsy |
2.6% |
Urinary Tract Infection |
2.6% |
Completed Suicide |
2.0% |
Condition Aggravated |
2.0% |
Drug Ineffective |
2.0% |
Irritability |
2.0% |
Speech Disorder |
2.0% |
Urinary Tract Disorder |
2.0% |
|
Secondary |
Epilepsy |
59.4% |
Partial Seizures |
25.0% |
Convulsion |
9.4% |
Petit Mal Epilepsy |
3.1% |
Seasonal Allergy |
3.1% |
|
Mental Impairment |
20.0% |
Syncope |
20.0% |
Somnolence |
10.0% |
Toxicity To Various Agents |
10.0% |
Urinary Tract Infection |
10.0% |
Urticaria |
10.0% |
Vitreous Floaters |
10.0% |
Weight Increased |
10.0% |
|
Concomitant |
Product Used For Unknown Indication |
32.7% |
Convulsion |
15.3% |
Epilepsy |
10.7% |
Complex Partial Seizures |
10.0% |
Headache |
7.3% |
Insomnia |
7.3% |
Pharyngitis Streptococcal |
7.3% |
Vitamin Supplementation |
7.3% |
Grand Mal Convulsion |
0.7% |
Temporal Lobe Epilepsy |
0.7% |
Urinary Incontinence |
0.7% |
|
Postictal State |
52.4% |
Cataract |
4.8% |
Convulsion |
4.8% |
Drug Dose Omission |
4.8% |
Muscle Spasms |
4.8% |
Retinopathy |
4.8% |
Sudden Unexplained Death In Epilepsy |
4.8% |
Urinary Tract Infection |
4.8% |
Vagal Nerve Stimulator Implantation |
4.8% |
Visual Field Defect |
4.8% |
Weight Increased |
4.8% |
|